To explore the mechanisms involved, we focused on the recently identified PLK1/AMPK/DRP1 signaling axis, which has been shown to inhibit ROS-mediated NLRP3 inflammasome activation and attenuate sepsis-induced acute lung injury [24]. This evidence concerns the gene PLK1 and Sepsis.